Mechanism of action of cisplatin on Na+/K+ ATPase of Caco-2 colon cells in vitro.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41734231.
- Also identified by DOI 10.1371/journal.pone.0342707 and PMC identifier 12931807.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cisplatin is a chemotherapeutic agent that reverts cancerous cells to the apoptotic route. A decrease in the activity of the Na+/K+ ATPase is one of the hallmarks of apoptosis and a major causative factor of the drug-induced nephrotoxicity. Whether cisplatin targets also the colonic ATPase is a question that was addressed in this work using Caco-2 cells as a model. ATPase activity was measured via inorganic phosphate release with and without ouabain, and protein expression was assessed by Western blot. Cisplatin reduced the activity of the Na+/K+ ATPase, an effect that was dependent on the transmembrane chloride gradient but had no effect on the purified enzyme, suggesting an indirect action. Fluorescence imaging showed a decrease in the membrane ATPase abundance. Cisplatin was shown to act by increasing intracellular calcium, triggering a sequential activation of p38MAPK and PKA that results in JNK inhibition and a decrease in the Na+/K+ ATPase activity.
Medical subject headings
- Sodium-Potassium-Exchanging ATPase
- Cisplatin
- Antineoplastic Agents
- Colon